Clinical trialPhase 2Unknown
High Dose Vitamin C Combined With Metformin in the Treatment of Malignant Tumors
Clinical Research of High Dose Vitamin C Combined With Metformin in the Treatment of Malignant Tumors
- Outcome
- Outcome unknown
- Phase
- Phase 2
- Status
- Unknown
- Study type
- Interventional
- Start
- 1 July 2020
- Listed end
- December 2024
- Enrollment
- 30 participants
- Sites
- 1
- Primary outcomes
- Progression-free survival
- Sponsor type
- Academic / other
- Results posted
- No
- Last update
- 28 September 2023
These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
This is an open, prospective, single-arm, multi-cohort clinical study to evaluate the efficacy and safety of high-dose vitamin C combined with metformin in the treatment of malignant tumors.